Incannex Healthcare Limited
IXHL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -82.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 100% | 100% |
| R&D Expenses | $9 | $5 | $2 | $4 |
| G&A Expenses | $10 | $4 | $6 | $5 |
| SG&A Expenses | $10 | $4 | $6 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$3 | $0 | $0 | $0 |
| Operating Expenses | $16 | $8 | $8 | $9 |
| Operating Income | -$13 | -$8 | -$8 | -$9 |
| % Margin | – | – | -41,701.5% | -8,451.4% |
| Other Income/Exp. Net | -$23 | $2 | -$1 | $1 |
| Pre-Tax Income | -$36 | -$7 | -$10 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$36 | -$7 | -$10 | -$8 |
| % Margin | – | – | -49,118.4% | -7,324.3% |
| EPS | -1.03 | -0.2 | -0.33 | -0.29 |
| % Growth | -415% | 39.4% | -13.8% | – |
| EPS Diluted | -1.03 | -0.2 | -0.33 | -0.29 |
| Weighted Avg Shares Out | 34 | 20 | 18 | 18 |
| Weighted Avg Shares Out Dil | 34 | 20 | 18 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$0 | $0 | $0 |
| EBITDA | -$39 | -$6 | -$9 | -$8 |
| % Margin | – | – | -46,643.3% | -7,268.9% |